About this condition
Hereditary Connective Tissue Disorders — Comprehensive
Hereditary connective tissue disorders (HCTDs) are a group of genetically distinct conditions sharing features of joint hypermobility, skin hyperextensibility, and vascular fragility — but with critically different aortic and vascular risk profiles. The major conditions include Marfan syndrome (FBN1), Loeys-Dietz syndrome (TGFBR1, TGFBR2, SMAD3, TGFB2, TGFB3), vascular Ehlers-Danlos syndrome (COL3A1), classical EDS (COL5A1, COL5A2), and others. These conditions affect approximately 1 in 3,000-5,000 people collectively.
The aortic dissection risk — the primary life-threatening complication — varies dramatically by gene. Marfan syndrome (FBN1) has a prophylactic aortic root replacement threshold of 5.0cm in adults without additional risk factors. Loeys-Dietz syndrome (TGFBR1/TGFBR2) has a lower threshold of 4.0-4.5cm because aortic dissection frequently occurs at smaller aortic diameters than Marfan. Vascular EDS (COL3A1) causes arterial rupture without preceding aneurysmal dilation — rupture occurs in normal-caliber arteries, requiring a fundamentally different surveillance strategy. These gene-specific aortic management differences directly affect survival.
Clinical overlap between HCTDs — tall stature, joint hypermobility, aortic root dilation, mitral valve prolapse, skin striae — makes clinical diagnosis unreliable without molecular testing. A patient clinically diagnosed with Marfan syndrome may actually have Loeys-Dietz syndrome (requiring more aggressive aortic surveillance and a lower surgical threshold) or familial thoracic aortic aneurysm (FTAAD, with different genetic counseling implications). The 2010 revised Ghent criteria for Marfan syndrome explicitly incorporate molecular FBN1 testing for diagnostic confirmation. All major aortic management guidelines now recommend gene-specific management.
Vascular EDS (COL3A1) causes arterial rupture without prior aneurysmal dilation — standard aortic diameter surveillance DOES NOT WORK for this condition. Management requires avoiding invasive vascular procedures whenever possible. Gene-specific diagnosis is life-saving.
- Gene locus
- FBN1 (15q21.1), TGFBR1 (9q22.33), TGFBR2 (3p24.1), SMAD3 (15q22.33), COL3A1 (2q32.2), ACTA2 (10q23.31)
